NCT01584115.
Trial name or title | Clinical trial of therapeutic vaccine with NY‐ESO‐1 in combination with the adjuvant monophosphoryl lipid A (MPLA) |
Methods | Uncontrolled phase I/II |
Participants | 15 participants with a NY‐ESO‐1‐expressing malignancy after standard treatment |
Interventions | Intramuscular injection with NY‐ESO‐1 combined with MPLA vaccine |
Outcomes | Adverse events Immune responses |
Starting date | July 2012 |
Contact information | |
Notes | Status unknown |